image
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.22
-4.77 %
$ 3.36 B
Market Cap
-179.5
P/E
INCOME STATEMENT
2.79 B REVENUE
16.73%
249 M OPERATING INCOME
21.99%
-73.9 M NET INCOME
-51.63%
EFFICIENCY
Earnings Waterfall Amneal Pharmaceuticals, Inc.
image
Revenue 2.79 B
Cost Of Revenue 1.77 B
Gross Profit 1.02 B
Operating Expenses 771 M
Operating Income 249 M
Other Expenses 323 M
Net Income -73.9 M
3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)3b(2b)1b(771m)249m(323m)(74m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 2 794.0 2 393.6 2 212.3 2 093.7 1 992.5 1 626.4 1 663.0 1 033.7 1 018.2 866.3 785.6
GROSS PROFIT
Cost Of Revenue 1 773.5 1 573.0 1 427.6 1 324.7 1 364.1 1 273.4 946.6 507.5 420.8 367.1 336.0
Gross Profit 1 020.4 820.6 784.7 769.0 628.4 353.0 716.4 526.2 597.5 499.2 449.6
OPERATING INCOME
Operating Expenses 771.1 616.2 595.8 575.1 517.3 491.9 440.9 301.0 323.5 277.8 239.6
Selling, General and Administrative Expenses 476.4 429.7 399.7 365.5 326.7 289.6 230.4 109.0 118.8 109.7 84.6
Research and Development Expenses 196.6 167.8 200.0 209.6 190.6 202.3 210.5 191.9 204.7 136.9 106.7
Operating Income 249.3 204.4 206.5 209.2 91.2 (137.4) (19.7) 245.1 284.9 227.2 222.9
PRE-TAX INCOME
Interest Income Expense 258.6 210.6 158.4 136.3 146.0 168.2 143.6 71.1 55.3 0 0
Total Other Income (304.3) (244.6) (153.2) (121.3) (126.9) 28.4 (183.0) (73.8) (70.1) (60.6) (39.2)
Pre-Tax Income (55.0) (40.3) (248.1) 31.4 (35.8) (220.2) (202.7) 171.3 214.8 175.6 179.3
NET INCOME
Tax Provision 18.9 8.5 6.7 11.2 (104.4) 383.3 (1.4) 2.0 5.4 5.0 1.5
Net Income (116.9) (84.0) (254.8) 20.2 68.6 (603.6) (169.7) 167.6 207.4 169.5 176.9
EPS 0.38 0.48 1.69 0.14 0.47 4.57 1.33 1.46 1.81 0.9 0